- Current report filing (8-K)
October 28 2010 - 3:07PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
October 28,
2010
ImmunoGen, Inc.
(Exact name of registrant as specified in its charter)
Massachusetts
|
|
0-17999
|
|
04-2726691
|
(State or other
jurisdiction of
incorporation)
|
|
(Commission File
Number)
|
|
(IRS Employer
Identification No.)
|
830 Winter Street, Waltham, MA 02451
(Address of principal executive offices) (Zip Code)
Registrants telephone number, including area code:
(781) 895-0600
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (
see
General
Instruction A.2. below):
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
ITEM 2.02 RESULTS OF OPERATION AND FINANCIAL CONDITION
On
October 28, 2010, ImmunoGen, Inc. (Nasdaq: IMGN) issued a press
release to announce the companys financial results for the quarter ended September 30,
2010. The press release announcing
financial results for the quarter ended September 30, 2010 is included as Exhibit 99.1
and incorporated herein by reference.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
(d): The following exhibit is being furnished
herewith:
Exhibit No.
|
|
Exhibit
|
|
|
|
99.1
|
|
Press
Release of ImmunoGen, Inc. dated October 28, 2010
|
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
ImmunoGen, Inc.
|
|
(Registrant)
|
|
|
Date:
October 28, 2010
|
/s/
Gregory Perry
|
|
|
|
Gregory
Perry
|
|
Senior
Vice President and Chief Financial Officer
|
3
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Jul 2023 to Jul 2024